Why Dubai and Abu Dhabi Are Building a Longevity Hub

A few years ago, anyone serious about a high-end longevity workup flew to California or Switzerland. Increasingly, the destination is the Gulf. Dubai and Abu Dhabi are now home to a growing cluster of clinics that sell the same promise as their Western peers, detailed diagnostics, personalized prevention, and treatments aimed at extending healthy years, but with two advantages those peers lack: heavy government backing and, in Abu Dhabi’s case, the world’s first regulatory framework written for longevity medicine.

The pull is not subtle. Abu Dhabi’s Department of Health introduced the world’s first licensing framework for what it calls Healthy Longevity Medicine Centres in October 2024, setting minimum standards for diagnostics, personalized interventions, and clinical governance. Dubai responded at the city level. In 2026, Sheikh Mohammed bin Rashid Al Maktoum issued a law establishing the Dubai Longevity Authority, a government body tasked with regulating the field from research through to patient clinics and positioning the emirate among the world’s top destinations for healthy life expectancy. When two of the region’s richest governments compete to host an industry, capital and clinics follow.

The regulation came first, then the clinics

What sets the UAE apart from the United States and Europe is that the rules arrived before the market matured. Abu Dhabi’s framework, effective from April 2025, defines what a longevity clinic must offer and how its staff must be qualified, including new licensing categories for health coaches, lifestyle medicine specialists, and exercise physiologists, according to the Department of Health.

In the United States, by contrast, longevity clinics operate in a regulatory gray zone, and critics regularly question the evidence behind their more aggressive offerings. The Gulf’s bet is that formal standards will make the sector look more like medicine and less like luxury wellness. That distinction matters to patients weighing a clinic abroad, and it feeds directly into the region’s broader push to grow medical tourism.

Abu Dhabi: state-owned giants move in

The clearest sign of intent came in January 2025, when the Department of Health licensed the Institute for Healthier Living Abu Dhabi (IHLAD) as the first specialized longevity medicine centre to meet the new standards. IHLAD is led by Dr. Nicole Sirotin, a lifestyle medicine physician and former chair of preventive medicine at Cleveland Clinic Abu Dhabi, and pitches AI-assisted, personalized care built around a patient’s biology and lifestyle.

The state holding company M42, formed in 2023 from the merger of G42 Healthcare and Mubadala Health, sits behind much of this infrastructure. M42 operates Cleveland Clinic Abu Dhabi, which runs its own preventive and longevity medicine programs, and the company has been folding longevity into its wider data strategy. In November 2025, M42 and Oracle announced a partnership to build unified, longitudinal patient records across the UAE, explicitly to prioritize prevention and healthy longevity. Separately, the state insurer and operator PureHealth won a DoH license for its Pura Longevity Clinic, described as its leading longevity science facility.

Dubai: luxury wellness meets clinical ambition

Dubai’s entry has leaned more toward premium, hospitality-led longevity. The Swiss brand Clinique La Prairie opened its first regional Longevity Hub at the One&Only One Za’abeel resort in March 2024, a 3,800-square-meter space with 29 treatment rooms offering assessments, IV therapies, cryotherapy, and longer wellness programs. It was the brand’s fifth such hub, after Madrid, Bangkok, Doha, and Taipei.

The city has also drawn data-led entrants. Biongevity, which describes itself as Dubai’s first precision health and longevity clinic, opened in September 2024 with genomics, body composition, cognitive testing, and AI-supported analysis, and has talked of expanding across the Gulf and into Silicon Valley, London, and Toronto. These ventures sit on the clinical end of a far larger consumer market, the broader trillion-dollar wellness economy that the UAE is actively courting through tourism and real estate.

The money behind the build-out

Government strategy is the engine. Dubai’s D33 economic agenda aims to double the emirate’s economy by 2033 and rank it among the top three cities for quality of life, and the new Dubai Longevity Authority is framed as a tool to hit those targets. Healthcare spending in Dubai is projected to reach AED 104 billion in the public sector and AED 22 billion in the private sector by 2027. The Dubai Healthcare City Authority has separately announced an AED 1.3 billion (about $354 million) expansion of its medical district, with delivery scheduled for 2027.

Saudi Arabia is the other heavyweight. The Riyadh-based Hevolution Foundation, funded by the Saudi government, has committed to investing up to $1 billion a year in aging research and, according to Al Arabiya, had deployed more than $400 million in grants to over 200 laboratories within roughly its first two years. That spending funds the underlying science, while the UAE concentrates on building the clinics where it might one day be applied.

How Gulf clinics compare to US and European peers

For now, the patient experience overlaps heavily with Western longevity medicine. Gulf clinics offer the familiar menu: advanced imaging, genomic and blood-based diagnostics, biological-age testing, and personalized lifestyle plans, much of it rooted in the same evidence-based functional and preventive medicine playbook used in California and Switzerland. The headline difference is structural rather than scientific. US clinics tend to be private and lightly regulated; Switzerland’s offerings center on long-established wellness destinations; the UAE is layering a state-defined regulatory standard on top, plus deeper public funding.

That does not settle the central debate. Much of longevity medicine still rests on screening and lifestyle intervention rather than proven life-extension, and the more experimental treatments, including some regenerative and stem-cell offerings advertised in the region, carry the same evidence questions they do everywhere. Regulation can raise the floor on safety; it cannot manufacture clinical proof that does not yet exist.

FAQ

Is longevity medicine in the UAE proven to extend life? No. Most of what these clinics offer is early detection, risk assessment, and lifestyle and preventive care, the same foundation used by reputable clinics worldwide. Claims of reversing or dramatically slowing aging remain unproven, and patients should treat aggressive promises with caution. This article is journalism, not medical advice.

What makes Abu Dhabi’s approach different from a US longevity clinic? Abu Dhabi created a formal licensing framework specifically for longevity medicine, with defined service and staffing standards, according to the Department of Health. Most US clinics operate without a dedicated regulatory category, so the Gulf model is built around government oversight from the start.

Who is funding all of this? The UAE governments through agendas like Dubai’s D33 and bodies like the Dubai Longevity Authority and M42, and, on the research side, Saudi Arabia’s Hevolution Foundation, which has pledged up to $1 billion a year for aging science.

Sources

1. Department of Health Abu Dhabi: world-first Healthy Longevity Medicine Centre standards
2. Gulf News: Sheikh Mohammed issues law establishing Dubai Longevity Authority
3. Abu Dhabi Media Office: DoH licenses Institute for Healthier Living Abu Dhabi
4. M42: Cleveland Clinic Abu Dhabi
5. Oracle: M42 and Oracle join forces to advance healthy longevity and disease prevention
6. PureHealth: DoH licenses Pura Longevity Clinic
7. Trade Arabia: Longevity Hub by Clinique La Prairie opens at Dubai resort
8. Invest in Dubai: healthcare investment and growth opportunities
9. Emirates News: Dubai Healthcare City AED 1.3 billion expansion
10. Al Arabiya: Saudi Arabia’s Hevolution Foundation commits to transform aging research